Amino acid-capped transition metal ion-doped iron oxide nanoparticles: evaluating drug delivery carrier efficiency and in vitro magnetic resonance image contrasting ability

De Mondal, Sucheta

DOI: https://doi.org/10.1007/s13738-023-02781-2

2023-03-20

Journal of the Iranian Chemical Society

Abstract:L-arginine capped and transition metal-doped Ultra-Small Iron Oxide Nanoparticles (USIONs) were synthesized by a wet chemical method. The nanoparticles (NPs) were encapsulated with Pluronic F127 ® and used as a vehicle (M 2+ /Fe 3 O 4 @L-Arg/P) to load anti-cancer drug. The interaction of ligand molecules with NPs surface was studied by FTIR spectroscopy, while the Vibrating Sample Magnetometry and Mössbauer spectroscopy were used for magnetic properties. In vitro, drug release kinetics showed that Mn 2+ /Fe 3 O 4 @L-Arg/P/bg release 30% drug initially within 5 h and the next 20% in 72 h with an overall 50% release in three days. Approximately, 70% drug was released from Ni 2+ /Fe 3 O 4 @L-Arg/P/bg. The Mn 2+ /Fe 3 O 4 @L-Arg/P/bg took a long time to 70% release rate than Zn 2+ and Ni 2+ -doped vehicles. M 2+ /Fe 3 O 4 @L-Arg/P/bg with 10 μg/mL dosage can reduce the cell viability to 53, 31, and 94 for Zn 2+ , Mn 2+ , and Ni 2+ , respectively. Contrasting ability of the material was evaluated for Magnetic Resonance Imaging (MRI). The results indicate a shift from inherent T 2 to T 1 contrasting with a lower concentration. The parameters (like τ M , τ R , q , etc.) used in Solomon–Bloembergen–Morgan (SBM) theory for paramagnetic relaxation also be applicable to Fe 3 O 4 -based NPs system in terms of H-bonding to modulate the T 1 contrasting in MRI.

chemistry, multidisciplinary